In treating aggressive lymphomas and blood cancer (leukemia), chimeric antigen receptor T cells (CAR T cells) are increasingly being used. For this therapy, immune cells are taken from patients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results